Drug intelligence / Profile preview

Curasept Afterapid

Development stage
Unknown
Lead developer
Curasept
Administration
Topical
01

Overview

Curasept Afterapid is a line of topical oral healthcare products, classified as Class 1 medical devices, developed by Curasept S.p.A. for the treatment of oral lesions including mouth ulcers, aphthous ulcers, and stomatitis. The formulation features a synergistic blend of mucoadhesive polymers, hydrolyzed DNA and RNA to accelerate tissue regeneration, and Biomoist hyaluronic acid to form a protective, moisturizing film. Additional active components include tea tree and manuka oils for antimicrobial properties, 18β-glycyrrhetinic acid for anti-inflammatory effects, ruscogenin for its astringent qualities, and allantoin and bisabolol to soothe and promote cell proliferation. Available as a mouthwash, gel, or spray, the product line is designed to provide rapid pain relief and speed up the natural healing process without the use of alcohol.

Brand names
Curasept Afterapid
02

Targets

DNA

Beyond the preview

Go deeper on Curasept Afterapid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curasept Afterapid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call